Cardiovascular Risk Reduction in Type 2 Diabetes:...

Diabetes Metabolic Syndrome and Obesity Targets and Therapy 2019 / 12 Vol. Volume 12

Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin

Avgerinos, Ioannis, Liakos, Aris, Tsapas, Apostolos, Bekiari, Eleni
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
Volume 12
Journal:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
DOI:
10.2147/DMSO.S190356
Date:
December, 2019
File:
PDF, 520 KB
2019
Conversion to is in progress
Conversion to is failed